BioNTech (BNTX) PT Lowered to $132 at Canaccord

October 14, 2026 6:35 AM

Canaccord analyst William Maughan lowered the price target on BioNTech (NASDAQ: BNTX) to $132.00 (from $136.00) while maintaining a Buy rating.

No results found